Visium secures strategic funding round backed by top-tier investors and unicorn founders
Summary
Visium SA closed its first institutional funding round co-led by Columbus Venture Partners and Concentric, with participation from a syndicate of unicorn founders; the amount raised was not disclosed. The Lausanne-based AI and data firm serves regulated industries including life sciences and specialty chemicals and lists clients such as Roche and Novartis. Visium will use the investment to accelerate expansion across Europe and the United States, scale its team, and extend its product capabilities while maintaining its dual consulting-and-product model. The company also strengthened its governance by appointing four new board members and three advisory board members to deepen scientific and commercial expertise.
Funding
Amount
None
Total raised
Date
May 20, 2026
Announcement date
Investors
Roche Venture Fund, Concentric, Novartis Venture Fund
Lead investors
Company
visium.ai
Funded company
Classifications
industries
No industries detected
applications
No applications detected
AskAI Classifications
Labels
No AI classifications detected